A detailed history of Assetmark, Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 93,159 shares of HALO stock, worth $4.43 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
93,159
Previous 84,774 9.89%
Holding current value
$4.43 Million
Previous $4.44 Million 20.08%
% of portfolio
0.02%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$51.3 - $64.42 $430,150 - $540,161
8,385 Added 9.89%
93,159 $5.33 Million
Q2 2024

Aug 13, 2024

SELL
$37.81 - $52.4 $876,208 - $1.21 Million
-23,174 Reduced 21.47%
84,774 $4.44 Million
Q1 2024

May 06, 2024

BUY
$33.68 - $41.95 $92,822 - $115,614
2,756 Added 2.62%
107,948 $4.39 Million
Q4 2023

Feb 09, 2024

BUY
$33.32 - $42.1 $1.46 Million - $1.84 Million
43,706 Added 71.08%
105,192 $3.89 Million
Q3 2023

Oct 27, 2023

SELL
$36.46 - $44.03 $600,459 - $725,130
-16,469 Reduced 21.13%
61,486 $2.35 Million
Q2 2023

Aug 11, 2023

BUY
$30.28 - $38.74 $1.22 Million - $1.56 Million
40,263 Added 106.82%
77,955 $2.81 Million
Q1 2023

May 05, 2023

BUY
$32.86 - $55.7 $274,906 - $465,986
8,366 Added 28.53%
37,692 $1.44 Million
Q4 2022

Feb 10, 2023

BUY
$40.06 - $59.44 $155,272 - $230,389
3,876 Added 15.23%
29,326 $1.67 Million
Q3 2022

Nov 01, 2022

BUY
$38.53 - $51.78 $896,593 - $1.2 Million
23,270 Added 1067.43%
25,450 $1.01 Million
Q2 2022

Aug 03, 2022

BUY
$37.35 - $48.3 $31,187 - $40,330
835 Added 62.08%
2,180 $96,000
Q1 2022

May 13, 2022

SELL
$31.97 - $41.06 $1,950 - $2,504
-61 Reduced 4.34%
1,345 $54,000
Q4 2021

Feb 14, 2022

BUY
$31.82 - $40.75 $1,622 - $2,078
51 Added 3.76%
1,406 $57,000
Q3 2021

Nov 12, 2021

BUY
$38.47 - $46.42 $4,616 - $5,570
120 Added 9.72%
1,355 $55,000
Q1 2021

May 14, 2021

BUY
$39.51 - $51.45 $12,050 - $15,692
305 Added 32.8%
1,235 $51,000
Q4 2020

Feb 10, 2021

BUY
$25.81 - $43.62 $23,616 - $39,912
915 Added 6100.0%
930 $40,000
Q4 2015

Sep 15, 2017

BUY
N/A
15
15 $0

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.